Plasma IDO activity could distinguish multi-drug resistance—TB (MDR-TB) from drug-susceptible TB and lung cancer. Higher plasma IDO activity can indicate a higher risk of MDR-TB. This evidence concerns the gene IDO1 and lung cancer.